-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Innovation Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Innovation Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$880K, a 38.4% increase year-over-year.
- Innovation Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$2.62M, a 44.5% increase year-over-year.
- Innovation Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.17M, a 55% increase from 2022.
- Innovation Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$7.04M, a 49.2% increase from 2021.
- Innovation Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.9M, a 109% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)